Non‐absorbable antibiotics for managing intestinal gas production and gas‐related symptoms
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Background: Simethicone, activated charcoal and antimicrobial drugs have been used to treat gas‐related symptoms with conflicting results. Aim: To study the relationship between gaseous symptoms and colonic gas production and to test the efficacy of rifaximin, a new non‐absorbable antimicrobial agent, on these symptoms. Methods: Intestinal gas production was measured by hydrogen (H 2) and methane (CH 4) breath testing after lactulose in 21 healthy volunteers and 34 functional patients. Only the 34 functional patients took part in a double‐blind, double‐dummy controlled trial, receiving, at random, rifaximin (400 mg b.d per 7 days), or activated charcoal (400 mg b.d per 7 days). The following parameters were evaluated at the start of the study and 1 and 10 days after therapy: bloating, abdominal pain, number of flatus episodes, abdominal girth, and cumulative breath H 2 excretion. Results: Hydrogen excretion was greater in functional patients than in healthy volunteers. Rifaximin, but not activated charcoal, led to a significant reduction in H 2 excretion and overall severity of symptoms. In particular, in patients treated with rifaximin, a significant reduction in the mean number of flatus episodes and of mean abdominal girth was evident. Conclusions: In patients with gas‐related symptoms the colonic production of H 2 is increased. Rifaximin significantly reduces this production and the excessive number of flatus episodes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Impaired colonic fermentation of carbohydrate after ampicillin
Rao, S. S. C., Edwards, C. A., Austen, C. J., Bruce, C., & Read, N. W. (1988) · Gastroenterology · doi:10.1016/0016-5085(88)90549-5 · Cited by 104
Fasting breath hydrogen in celiac disease
Corazza, G. R., Strocchi, A., & Gasbarrini, G. (1987) · Gastroenterology · doi:10.1016/0016-5085(87)90313-1 · Cited by 101
Self-citation
Cited by
Intestinal microbiota in functional bowel disorders: a Rome foundation report
Simrén, M., Barbara, G., Flint, H. J., Spiegel, B. M. R., Spiller, R. C., Vanner, S., Verdu, E. F., Whorwell, P. J., & Zoetendal, E. G. (2013) · Gut · doi:10.1136/gutjnl-2012-302167 · Cited by 939
Small intestinal bacterial overgrowth syndrome
Bures, J. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i24.2978 · Cited by 620
SILK, D. B. A., DAVIS, A., VULEVIC, J., TZORTZIS, G., & GIBSON, G. R. (2009) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2008.03911.x · Cited by 551
(2009) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2009.03951.x · Cited by 444
Sharara, A. I., Aoun, E., Abdul-Baki, H., Mounzer, R., Sidani, S., & ElHajj, I. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00458.x · Cited by 344
“13 ), and in managing intestinal gas production and related symptoms in open-label trials involving patients with functional abdominal symptoms and uncomplicated diverticular disease”
Background
Metadata
- Authors
- Di Stefano, M., Strocchi, A., Malservisi, S., Veneto, G., Ferrieri, A., & Corazza, G. R.
- Venue
- Alimentary Pharmacology & Therapeutics
- Publisher
- Wiley
- Published
- 2000-08
- Volume
- 14
- Issue
- 8
- Pages
- 1001-1008
- ISSN
- 0269-2813 (ISSN-L)
- 1365-2036
- OpenAlex
- W2034777528
- Cited by
- 95
- References
- 2
- FWCI
- 3.35
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Non‐absorbable antibiotics for managing intestinal gas production and gas‐related symptoms. https://app.cochat.ai/papers/10.1046/j.1365-2036.2000.00808.x
- The paper
- Di Stefano, M., Strocchi, A., Malservisi, S., Veneto, G., Ferrieri, A., & Corazza, G. R. (2000). Non‐absorbable antibiotics for managing intestinal gas production and gas‐related symptoms. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1046/j.1365-2036.2000.00808.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.